Loading…

[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy

The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders 2013-02, Vol.28 (2), p.169
Main Authors: Shimada, Hitoshi, Shinotoh, Hitoshi, Hirano, Shigeki, Miyoshi, Michie, Sato, Koichi, Tanaka, Noriko, Ota, Tsuneyoshi, Fukushi, Kiyoshi, Irie, Toshiaki, Ito, Hiroshi, Higuchi, Makoto, Kuwabara, Satoshi, Suhara, Tetsuya
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 169
container_title Movement disorders
container_volume 28
creator Shimada, Hitoshi
Shinotoh, Hitoshi
Hirano, Shigeki
Miyoshi, Michie
Sato, Koichi
Tanaka, Noriko
Ota, Tsuneyoshi
Fukushi, Kiyoshi
Irie, Toshiaki
Ito, Hiroshi
Higuchi, Makoto
Kuwabara, Satoshi
Suhara, Tetsuya
description The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]
doi_str_mv 10.1002/mds.25286
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1317464282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920073161</sourcerecordid><originalsourceid>FETCH-proquest_journals_13174642823</originalsourceid><addsrcrecordid>eNqNyrFqQjEUgOEgLfRWO_QNDjg4xebkmmtWEaWzuEmRSE4xNtdoTkRun74Ounf6h_8T4h3VGJXSH63nsTbaNj1RoalRWm2mT6JS1hpZozUv4pX5oBSiwaYSq82OivuSru1iCh7CESJdO9gl34EPTI4JAkOm6Ap5KAlm8XdPoaU84oeQMfwQuJLTad8NxPO3i0xv9_bFcLlYzz_lKafzhbhsD-mSj7e1xRqnk2aira7_p_4AYc1E2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317464282</pqid></control><display><type>article</type><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</creator><creatorcontrib>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</creatorcontrib><description>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.25286</identifier><identifier>CODEN: MOVDEA</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Movement disorders</subject><ispartof>Movement disorders, 2013-02, Vol.28 (2), p.169</ispartof><rights>Copyright © 2012 Movement Disorders Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Hirano, Shigeki</creatorcontrib><creatorcontrib>Miyoshi, Michie</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Tanaka, Noriko</creatorcontrib><creatorcontrib>Ota, Tsuneyoshi</creatorcontrib><creatorcontrib>Fukushi, Kiyoshi</creatorcontrib><creatorcontrib>Irie, Toshiaki</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Kuwabara, Satoshi</creatorcontrib><creatorcontrib>Suhara, Tetsuya</creatorcontrib><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><title>Movement disorders</title><description>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</description><subject>Movement disorders</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNyrFqQjEUgOEgLfRWO_QNDjg4xebkmmtWEaWzuEmRSE4xNtdoTkRun74Ounf6h_8T4h3VGJXSH63nsTbaNj1RoalRWm2mT6JS1hpZozUv4pX5oBSiwaYSq82OivuSru1iCh7CESJdO9gl34EPTI4JAkOm6Ap5KAlm8XdPoaU84oeQMfwQuJLTad8NxPO3i0xv9_bFcLlYzz_lKafzhbhsD-mSj7e1xRqnk2aira7_p_4AYc1E2A</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Shimada, Hitoshi</creator><creator>Shinotoh, Hitoshi</creator><creator>Hirano, Shigeki</creator><creator>Miyoshi, Michie</creator><creator>Sato, Koichi</creator><creator>Tanaka, Noriko</creator><creator>Ota, Tsuneyoshi</creator><creator>Fukushi, Kiyoshi</creator><creator>Irie, Toshiaki</creator><creator>Ito, Hiroshi</creator><creator>Higuchi, Makoto</creator><creator>Kuwabara, Satoshi</creator><creator>Suhara, Tetsuya</creator><general>Wiley Subscription Services, Inc</general><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20130201</creationdate><title>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</title><author>Shimada, Hitoshi ; Shinotoh, Hitoshi ; Hirano, Shigeki ; Miyoshi, Michie ; Sato, Koichi ; Tanaka, Noriko ; Ota, Tsuneyoshi ; Fukushi, Kiyoshi ; Irie, Toshiaki ; Ito, Hiroshi ; Higuchi, Makoto ; Kuwabara, Satoshi ; Suhara, Tetsuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_13174642823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Movement disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Hirano, Shigeki</creatorcontrib><creatorcontrib>Miyoshi, Michie</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Tanaka, Noriko</creatorcontrib><creatorcontrib>Ota, Tsuneyoshi</creatorcontrib><creatorcontrib>Fukushi, Kiyoshi</creatorcontrib><creatorcontrib>Irie, Toshiaki</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Kuwabara, Satoshi</creatorcontrib><creatorcontrib>Suhara, Tetsuya</creatorcontrib><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimada, Hitoshi</au><au>Shinotoh, Hitoshi</au><au>Hirano, Shigeki</au><au>Miyoshi, Michie</au><au>Sato, Koichi</au><au>Tanaka, Noriko</au><au>Ota, Tsuneyoshi</au><au>Fukushi, Kiyoshi</au><au>Irie, Toshiaki</au><au>Ito, Hiroshi</au><au>Higuchi, Makoto</au><au>Kuwabara, Satoshi</au><au>Suhara, Tetsuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy</atitle><jtitle>Movement disorders</jtitle><date>2013-02-01</date><risdate>2013</risdate><volume>28</volume><issue>2</issue><spage>169</spage><pages>169-</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><coden>MOVDEA</coden><abstract>The aim of this study was to investigate whether amyloid deposition is associated with Alzheimer's disease (AD)-like cortical atrophy in Lewy body (LB) disease (LBD). Participants included 15 LBD with dementia patients (8 with dementia with Lewy bodies [DLB] and 7 with Parkinson's disease [PD] with dementia [PDD]), 13 AD patients, and 17 healthy controls. Age, gender, and Mini-Mental State Examination scores were matched between patient groups. All subjects underwent PET scans with [11C]Pittsburgh Compound B to measure brain amyloid deposition as well as three-dimensional T1-weighted MRI. Gray-matter volumes (GMVs) were estimated by voxel-based morphometry. Volumes-of-interest analyses were also performed. Forty percent of the 15 DLB/PDD patients were amyloid positive, whereas all AD patients and none of the healthy controls were amyloid positive. Amyloid-positive DLB/PDD and AD patients showed very similar patterns of cortical atrophy in the parahippocampal area and lateral temporal and parietal cortices, with 95.2% of cortical atrophy distribution being overlapped. In contrast, amyloid-negative DLB/PDD patients had no significant cortical atrophy. Compared to healthy controls, parahippocampal GMVs were reduced by 26% in both the amyloid-positive DLB/PDD and AD groups and by 10% in the amyloid-negative DLB/PDD group. The results suggest that amyloid deposition is associated with AD-like atrophy in DLB/PDD patients. Early intervention against amyloid may prevent or delay AD-like atrophy in DLB/PDD patients with amyloid deposition. © 2012 Movement Disorder Society [PUBLICATION ABSTRACT]</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/mds.25286</doi></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2013-02, Vol.28 (2), p.169
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_journals_1317464282
source Wiley-Blackwell Read & Publish Collection
subjects Movement disorders
title [beta]-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A18%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5Bbeta%5D-amyloid%20in%20lewy%20body%20disease%20is%20related%20to%20Alzheimer's%20disease-like%20atrophy&rft.jtitle=Movement%20disorders&rft.au=Shimada,%20Hitoshi&rft.date=2013-02-01&rft.volume=28&rft.issue=2&rft.spage=169&rft.pages=169-&rft.issn=0885-3185&rft.eissn=1531-8257&rft.coden=MOVDEA&rft_id=info:doi/10.1002/mds.25286&rft_dat=%3Cproquest%3E2920073161%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_13174642823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1317464282&rft_id=info:pmid/&rfr_iscdi=true